Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Inhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation.
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.
Preparation and characterization of Δ(9)-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines.
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes.
Adolescents' experiences on coping with parental multiple sclerosis: a grounded theory study.
New TYSABRI® analysis at AAN annual meeting shows improved walking speed in significant number of MS patients
Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome.
Human endogenous retroviruses and the nervous system.
Complications of Immunosuppressive/Immunomodulatory Therapy in Neurological Diseases.
CC3-03: Drug Characteristics Associated with Medication Adherence Across Eight Disease States.
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis.
Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions.
The first 10 years with multiple sclerosis: The longitudinal course of daily functioning.
Cross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population.
Correlation analysis of visual analogue scale and measures of walking ability in multiple sclerosis patients.
Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis.
Vitamin D and axonal injury in multiple sclerosis.
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.
Influence of the use of statin on the stability of erythrocyte membranes in multiple sclerosis.
Potent and orally efficacious bisthiazole-based histone deacetylase inhibitors.
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex.
Autoimmune hepatitis in a patient affected by neuromyelitis optica: A new association.
Decoding Signaling and Function of the Orphan G Protein-Coupled Receptor GPR17 with a Small-Molecule Agonist.
The neurology of Sjogren's syndrome and the rheumatology of peripheral neuropathy and myelitis.
Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
Pages
« first
‹ previous
…
271
272
273
274
275
276
277
278
279
…
next ›
last »